“…Methods that have been described in the literature include pre-treatment with erythropoietin (18), preoperative haemodilution with intraoperative blood salvage (16), surgical techniques such as gentle soft tissue handling and meticulous haemostasis (7), bipolar sealers (19, 20), intravascular occlusion (21), haemostatic agents (22), and early removal of drains (8, 23). However, the preponderance of the literature investigating clinical outcomes of THA in Jehovah's Witnesses was published over two decades ago, and the few studies that enrolled large numbers of patients focused on the perioperative period rather than long-term follow-up (9, 18, 21, 24–25–26–27–28). To the best of our knowledge, there is no study of this patient population that has investigated implant survivorship, mid-term clinical outcomes, and mortality following primary THA in the setting of a comprehensive blood management strategy.…”